Early Commercial Lead - Fibrostenosing Crohn’s Disease Department: Business Development Employment Type: Full Time Location: Agomab Antwerp Description We are looking for an Early Commercial Lead to shape the commercial strategy for Ontunisertib, a GI-restricted small molecule ALK5 inhibitor current